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An E. cali plasmid expressing efficiently an artificial precursor of bovine leukemia virus (BLV) proteinase under transcriptional control of the phage 
T7 promoter was constructed. The expression product accumulates in the induced E. coii cells in the form of insoluble cytoplasmic inclusions. 
Solubilization of the inclusions and a refolding step yield almost pure and completely self-processed proteinase. Purification to homogeneity was 
achieved by ion-exchange chromatography and reverse-phase HPLC. On a preparative scale, a high yield of enzymatically active proteinase was 
obtained. An initial study using a series of synthetic peptide substrates hows a distinct substrate specificity of BLV proteinase. 
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I. INTRODUCTION 
Bovine leukemia virus (BLV), the causative agent of 
chronic leukemia in cattle, sheep and goats, requires in 
its life cycle, like other retroviruses, specific activity of 
a virally coded processing proteinase [l], 
DNA sequence homology analysis reveals that BLV is 
ctosely related to human T-cefI leukemia viruses 
HTLVl and HTLV2 (see [2]). The nucleotide sequence 
of provirat BLV DNA was determined independently in 
two laboratories [3,4]. Comparison of the deduced 
amino acid sequence with the sequence of proteinase 
isolated from virions [S] indicates that the proteinase is 
coded for by its own reading frame, different from both 
gag and pal genes. The synthesis of the polyprotein 
precursor Gag-Pro-PO1 thus requires two frameshift 
events (one upstream and one downstream of the pro- 
teinase ORF) at sites whose exact positions, however, 
have not been determined conclusively f2]. In contrast 
to HIV1 proteinase which is, for obvious reasons, pro- 
bably the best characterized retroviraf processing pro- 
teinase (see e.g. [6,7]), data on the BL?’ enzyme remain 
rather scanty. 
We report here the construction of an E. coli expres- 
sion plasmid (pB603T7Q) that encodes an artificiat 22 
kDa proteinase precursor. This precursor undergoes ac- 
curate selfprocessing in vitro, yieiding an active 14 kDa 
enzyme. Preliminary characterization of substrate 
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specificity of the mature, chroma~ographicalIy purified 
recombinant enzyme is also described. 
2. EXPERIMENTAL 
The source of a coding sequence of BLV proteinase was the 823 bp 
Smr3A fragment (nt 1756 to 2578, 141) from pBLV {a plasmid con- 
prising full-length BLV proviral DNA, provided generously by Dr. N. 
Sagata). This fragment was placed under transcriptional and transla- 
tional control of bacteriophage T7 gene 10 in a vector pT7Q9 (M.F. 
and M.A., unpublished resultsf, a derivative of pRKf72 [S], yielding 
the expression ptasmid pH603T7Q. A host strain E. co/i BL_21(DE3) 
conta~njng une copy of T? RNA ~o~ymerase g ne in its genome (as 
detailed in [9]), was used to overexpress the proteinase precursor from 
pB603T7Q. Bacteria were grown in a rich medium containing 100 
Ag/rnl ampicillin and 25% glycerol at 37°C in flasks on a roiary 
shaker. The expression of the BLV proteinase precursor was induced 
at Also = 1.2-l .5 by adding IPTG to a final concentration of 1 mM 
and the cells were harvested 90 min after induction. Cell lysates were 
obtained by a freeze-thaw cycle, addition of Iysozyme and sonication. 
Cytoplasmic inclusions were pelleted and washed with 0.1% Triton 
X-100 [IO]. The pellets of inclusion bodies were suspended in 0.5 ml 
of 0.2 M Tris-HCI JpH 7.0), 0.1 M sodium phosphate, 0.2 M NaCI, 
0.01 M EDTA, 0.5% 2-mercaptoethano~, and dissolved in 10 ml of 
warm sarurared solution of urea, and dialyzed overnight at 4°C 
against 3 litres of 0.01 hl sodium acetate (pH 5), O.OOZ M EDT.&., 20% 
gIycerol, 5% ethyteneglycol, The diaIysate was centrifuged and the 
mature proteinase contained main& in the supernatant was purified 
by SE-Sephadex chrolnatography and HPLC on C4 Vydac column 
(see brction 3 for detailed procedures). 
Acrivir~ rrssu~~. in the course of purification the BLV proteinase ac- 
tivity was assayed against the peptidcs PPAlL.PIIS and 
QPAVLNphVAP in 0.05 M sodium acetate (pH 5.3), 0.3 M NaCl at 
37’C. Cleavage products were detected by HPLC (Vydac CIR col- 
umn, linear methanol gradient). The specificity studies were perform- 
ed under the same conditions (salt concentration, pH, temperature) 
using 0.4-0.8 mM concentrations of substrates incubated for 1 h in a 
final volume of 60 ~1 with 1 119 of proteinase. 
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Aliiino-termiilal amino acid tequencci were deter-mined with an 
,Appllecl Uio~!~temi 17OA protein wquenccr. 
3. RESULTS AND DISCUSSION 
Heterologous expression in E. co/i has proved a 
useful source of avian (e.g. [ 101) as well as mammalian 
(e.g. (111) retroviral proteinases in preparative amounts 
(for review see [6,7]). 
In order to overexpress BLV proteinase in E. co/i we 
constructed plasmid pB603T7Q based on the phage T7 
RNA polymeraseipromoter system [9] (see section 2). 
Similar expression vectors have been used for expres- 
sion of HIV-I proteinasc (e.g. [I I], see also [7]). The ex- 
pected primary translation product of pB603T7Q is a 
fusion protein containing 4 amino acids derived from 
phage T7 gene 10 and linker, followed by BLV pro- 
teinase ORF sequence which comprises 126 amino acids 
of mature proteinase flanked on both N and C termini 
by 42 and 26 amino acids, respectivety (Fig. 1). The ex- 
act sites of ribosomal frameshifts occurring during 
translation of viral messenger in infected eukaryotic 
cells are not known. Thus, it is not possible to surmise 
how far upstream and downstream of mature pro- 
teinase, the reading frame of our artificial precursor 
corresponds to that of the Gag-Pro and/or Gag-Pro- 
Pol viral translates. Regardless of this, both cleavage 
sites are preserved, making the artificial 22 kDa precur- 
sor synthesized in E. coli a potential substrate for 
selfprocessing leading to a mature 14 kDa proteinase. 
All E. cofi BL2lfDE3)/pB603T7Q cells in induced 
culture formed cytoplasmic inclusion bodies. The inclu- 
sions formed within 90 min following induction con- 
tained unprocessed 22 kDa precursor as a major com- 
ponent (Fig. 2, lane 3). Some minor in vivo processing 
(of various extent in individual cultivations) was 
regularly observed (analyses not shown). Prolonged, 
o\:ernight cultivations yielded a processed 14 kDa pro- 
tein which, however, lacked proteolytic activity in in 
vitro assays. The 90 min induction period was therefore 
chosen for all experiments. The 22 kDa artificial 
precursor thus obtained was found to undergo readily 
selfprocessing in vitro, i.e. in the course of solubiliza- 
tion of inclusion bodies and subsequent dialysis. The 
T? oromoter 
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Fig. 1, Construction of BLV proteinase expre\Gon plasmid. Phage T7 
promoter direc[s synthesis of a recombinant precursor comprising 4 
hector-derived amino acids and 194 amino acids of BLV proteinase 
reading frame. The cleavage sites and Ihc surrounding ~eyuences a1 
both rhe N-and C-termini of the mature prottinaie are indicated. PK, 
l.ig. 2. BI+V proteinaw e\pre,,ion in IPTCi-induced E. co/i 
BL2l(Df3)/pB603T7Q. SDS-PAGE ihow the prorein composition 
of the L‘cII lysale (lanr 1); ,olublc cytuplarmic t’l-action (lane 2); 
diiwlwd inclusions (lane 3); supetnatant (lane 4) and \ediment (lane 
5) al’tet dialyv\ of the di\sohed inclualony homogrnco~~s St- 
Sephades and HPLC purii‘ied HLV proreinae (lane 6). Silver stain- 
ing, 18% SDS-PAGE. ?hc molecular weighi marker\ XC Indicated on 
proreinaic; aa, amino acid. the right. I-or detail\ set re\;r. 
resultant 14 kDa soluble protein (Fig. 2, cornpare lanes 
3 and 4) displayed proteolytic activity. Due to the lo\+ 
solubility of BLV proteinase, some of the processed en- 
zyme, as well as \,arying amounts of the unprocessed 
precursor were trapped in the precipitate (Fig. 2, lane 5) 
that had formed during dialysis. I’ields of the active 
mature enzyme Lvere further improved by subjecting the 
insoluble precipitate to additional rounds of solubiliza- 
tion/dialysis procedure. 
The soluble fraction obtained after dialysis of 
dissolved inclusions is sLlbsta~ltiall~ enriched for the 
mature proteinasc and shows a high degree of purity on 
SDS-PAGE (Fig. 2, Iane 4). Further pul-ification is 
achieved by SE-Sephadex column chromatography 
(Fig. 3a), which removes unprocessed precursor, pep- 
tide contaminants and most of lysozyme thar was added 
when lysing the cells. BLV proteinasc elutes at 0.23 M 
NaCl in the NaCl gradient (O-l %l, in sodium acetate 
buffer pH 5.0) (Fig. 3a). Similar elution profiles \vere 
observed with MAV and HIV1 protcinases ([12] and 1. 
Pichov& personal communic~~t~oll). The final purifica- 
tion by HPLC (Fig. 3b) removes the last traces of con- 
taminants and results in a ho~]o~eIleous pl-eparation of 
the enzyme (Fig. 2, lane 6). In all, 7 g of wet cell paste 
yielded approx. 1 g of leashed inclusion bodies and 
these in turn yielded approx. 25 mg of homogeneous en- 
zyme. 
The N-terminal sequence LSIPLARSRP determined 
for SE-Sephadex and HPLC purified mature 14 kDa 
proteinase corresponds with that of the enzyme isolated 
from BLV virions IS]. The identical N-terminal se- 
quences of the natural and recombinant enzymes sug- 
gest that the processing of the recombinant precursor at 
the amino terminus is accurate. 
kD 
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Fig. 3. Purification of BLV proteinase by chromatography on (a) SE-Sephadex and (b) reverse-phase HPLC. (a) The SE-Sephadex column was 
equilibrated in 0.05 M sodium acetate, pH 5. An elution gradient of NaCl was applied as indicated by the concentration curbe. Solid line, elution 
profile; dotted line, NaCl gradient. (b) The material obtained after the catioa-exchange chromatography \\as applied to a C4 Vydac column in 
water with 0.05% trifluoroacetic acid (TFA) and eluted with a gradient of acetonitrile containing 0.05% TFA. PR, proteinase; LZ, lysozyme. 
The substrate specificity of the recombinant BLV 
proteinase was analyzed using a series of synthetic pep- 
tides representing putative cleavage sites of BLV, 
HTLVl, HIV1 and MAV polyproteins (Table I). Pep- 
tides 1, 2 and 3 are based on natural cleavage sites 
within BLV polyproteins [5], and peptide 5 is designed 
Table I 
Cleavage of synthetic substrates by BLV proteinase 
Peptide substrate Origin Relative 
cleavage 
I ELECL*LSIPL BLV n/PR 1.00 
2 PPMVG*VLDAP BLV PR/pl3 0.60 
3 PPAIL*PlIS BLV MA/CA 0.90 
4 QPALL*VHTP BLV CA/ NC <O.Ol 
5 QPAVL*NphVAP Consensus C-type 0.65 
6 APQVL*PVMHP HTLVl MA/CA 0.55 
7 KARVY*NphEANle HIV1 CA/X (modified) 0 
8 KARVL*NphEAM HIV1 CA/X (modified) 0 
9 ATFQA*NphPLREA MAV RT/IN (modified) 0 
IO ATHQVY*NphVRKA MAV RT/IN (modified) 0 
Peptides l-4 and 6 were designed according to processing sites of BLV 
[S] and HTLVl [14] polyproteins, respectively; 5 is a chromogenic 
peptide, representing a consensus processing site based on target sites 
of polyproteins of C-type retroviruses [13]; 7-10 are prominent 
chromogenic peptide substrates based on HIV1 CA/X target site (7,8) 
[I51 and on MAV RT/IN target site (9,lO) [13]. The nomenclature of 
retroviral proteins is according to [16]. 
The asterisk indicates the expected cleavage site. Nph, 4 - nitro- 
phenylalanine; Nle, norleucine. The hydrolysis was followed by 
HPLC and amino acid analysis of cleavage products. The relative 
cleavage rates were calculated from the integrated areas of substrate 
and product peaks. For conditions see section 2. 
according to the consensus substrate sequence of pro- 
teinases of C-type retrovirus family [13]; they all were 
hydrolyzed readily. For peptide 1, K,,, value 47 PM and 
lirln12 pm01 min -1 .mgmr were determined. In contrast, 
peptide 4 based on the BLV CA/NC processing site [5] 
was cleaved poorly. Interestingly, peptides 4 and 5 dif- 
fer strikingly in their rate of cleavage, despite having 
almost identical non-prime residues. Much slower 
cleavage of peptide 4 is probably caused by the presence 
of a His residue in the P2’ position; in most retroviral 
proteinases studied so far, small hydrophobic side 
chains are preferred in P2 or P2’. The His residue in 
1’2’ is unfavourable and synthetic peptide is cleaved 
poorly. In native polyprotein this might be compen- 
sated by other effects, like aggregation. With MAV 
proteinase we have also observed that some sequences 
which are efficiently processed in the virus were poorly 
cleaved in synthetic peptides [12,13]. The substrate 6 
corresponding to HTLVl MA/CA junction [14] was 
also cleaved efficiently. 
Peptides 7 to 10 were found almost resistant to the 
BLV proteinase under the conditions used. Peptides 7 
and 8 are prominent substrates of HIV1 proteinase 
(with K,,, values lower than 15 ,uM and k,,( higher than 
10 s- ’ under similar conditions [ 151, and peptides 9 and 
10 are good chromogenic substrates of MAV proteinase 
[ 131. Nitrophenylalanine residue (Nph) introduced into 
Pl’ position of peptides 5, 7, 8, 9 and 10 [13,15] in- 
creases extinction coefficients and improves detection 
of cleavage products on HPLC. 
The substrate specificity of the BLV proteinase as 
characterized up to now is substantially distinct from 
131 
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that of HIV1 and MAV proteinases. Possible similarity 
of BLV and HTLV proteinases should be further 
studied. 
In conclusion, we have constructed an efficient 
system for bacterial expression of enzymatically active 
BLV proteinase, as witnessed by accurate selfprocessing 
of its precursor, and by specific cleavage of synthetic 
peptide substrates by the mature enzyme. 
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